Cognex director exercises 8,324 RSUs into shares

COGNEX CORP director John Tseng-Chung Lee reported equity compensation activity involving restricted stock units and common shares.

Rhea-AI Filing Summary

COGNEX CORP director John Tseng-Chung Lee reported equity compensation activity involving restricted stock units and common shares. On February 18, 2026, he exercised 8,324 restricted stock units for 8,324 shares of common stock at a price of $0.00 per share, bringing his direct common stock holdings to 21,907 shares.

On February 17, 2026, he received a grant of 4,817 restricted stock units, and a separate line shows 2,913 restricted stock units held directly after another transaction. Each restricted stock unit represents the right to receive one share of Cognex common stock, with footnotes indicating these awards vest 100% on the first anniversary of their respective grant dates.

Insider Trade Summary

8,324 shares exercised/converted

Exercise 4 txns

Insider Lee John Tseng-Chung

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	8,324	$0.00	$0.00
Exercise	Common Stock	8,324	$0.00	$0.00
Grant/Award	Restricted Stock Unit	4,817	$0.00	$0.00
holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 7,730 contracts for 2,913 underlying shares (Direct); Common Stock — 21,907 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
2. F2. The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025).
3. F3. The restricted stock units vest 100% on the first anniversary of the grant date (February 17, 2026).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Cognex (CGNX) director John Lee report?

Director John Tseng-Chung Lee reported exercising 8,324 restricted stock units into common stock and receiving a grant of 4,817 new restricted stock units. These transactions are equity compensation-related rather than open-market purchases or sales, and all holdings are reported as directly owned.

Did the Cognex (CGNX) director buy or sell shares on the open market?

The filing shows no open-market buying or selling. Instead, John Tseng-Chung Lee exercised 8,324 restricted stock units into common stock at $0.00 per share and reported new restricted stock unit grants, all as part of equity compensation arrangements.

How many Cognex (CGNX) common shares does John Lee hold after these transactions?

After exercising restricted stock units on February 18, 2026, John Tseng-Chung Lee directly holds 21,907 shares of Cognex common stock. This total reflects the conversion of 8,324 restricted stock units into common shares as reported in the Form 4 filing.

What new restricted stock units were granted to the Cognex (CGNX) director?

On February 17, 2026, John Tseng-Chung Lee was granted 4,817 restricted stock units. Each unit represents a right to receive one Cognex common share, with the units vesting 100% on the first anniversary of the grant date, according to the filing footnotes.

When do John Lee’s Cognex (CGNX) restricted stock units vest?

The footnotes state certain restricted stock units vest 100% on the first anniversary of their respective grant dates. One award vests on February 18, 2025, and another vests on February 17, 2026, aligning vesting with one-year service periods after each grant.

What does each Cognex (CGNX) restricted stock unit represent for the director?

Each restricted stock unit represents a contingent right to receive one share of Cognex common stock. Upon vesting and settlement, these units convert into common shares, as illustrated by the February 18, 2026 transaction where 8,324 restricted stock units were exercised into 8,324 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lee John Tseng-Chung

(Last) (First) (Middle)

1 VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		M		8,324	A	$0.0	21,907	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/18/2026		M			8,324	02/18/2026(2)	02/18/2026	Common Stock	8,324	$0.0	0	D
Restricted Stock Unit	(1)	02/17/2026		A		4,817		02/17/2027(3)	02/17/2027	Common Stock	4,817	$0.0	4,817	D
Restricted Stock Unit	$0.0							02/21/2024	02/21/2026	Common Stock	2,913		2,913	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025).

3. The restricted stock units vest 100% on the first anniversary of the grant date (February 17, 2026).

	John Tseng-Chung Lee	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.